January 15, 2014
This article was reported by Science Codex.
Science Codex reported the results of an Albert Einstein College of Medicine of Yeshiva University study of hepatitis C prevalence among US Hispanic groups. The study's analysis of data gathered for the National Institutes of Health (NIH)-funded Hispanic Community Health Study/Study of Latinos indicated hepatitis C infection varied widely among Hispanic groups and was much more likely among Puerto Rican Hispanics. The NIH study collected data on 11,964 Hispanic adults from the Bronx, Miami, Chicago, and San Diego.
The Albert Einstein study authors were unable to explain why hepatitis C prevalence was higher among Puerto Rican Hispanics. Lead Author Mark Kuniholm urged community-based campaigns to increase hepatitis C testing and treatment among Hispanics and to focus extra effort on communities with large Puerto Rican populations, such as the Bronx or Chicago.
In 2012, CDC recommended that baby boomers and people with increased risk have hepatitis C tests. The US Food and Drug Administration recently approved new hepatitis C medications that could cure more than 80 percent of hepatitis C infections.
The full report, "Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results from the NHANES 20072010 and HCHS/SOL Studies," was published online in the Journal of Infectious Diseases (2014; doi: 10.1093/infdis/jit672).
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade|
|CROI 2018: Highlights and What's Next for Advocates|
|Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence|
|Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives|
|Statin Use Might Reduce Risk of Cancer in HIV-Positive People|
|Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say|